Literature DB >> 11953551

Exertional compartment syndrome and the role of magnetic resonance imaging.

Tamara D Lauder1, Michael J Stuart, Kimberly K Amrami, Joel P Felmlee.   

Abstract

A 47-yr-old woman presented with a 1-yr history of progressive bilateral anterior lower leg pain and swelling with walking, which resolved 10 min after activity. Postexercise (forced dorsiflexion) magnetic resonance imaging revealed increased T2 signal intensity in the entire anterior muscle compartment, and anterior compartment pressures were elevated at rest and postexercise. Chronic exertional compartment syndrome can occur in some patients after even minimal physical activities, and magnetic resonance imaging without the use of radioisotopes was a useful adjunct for diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 11953551     DOI: 10.1097/00002060-200204000-00016

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  4 in total

1.  A NON-OPERATIVE APPROACH TO THE MANAGEMENT OF CHRONIC EXERTIONAL COMPARTMENT SYNDROME IN A TRIATHLETE: A CASE REPORT.

Authors:  Cristiana Kahl Collins; Brad Gilden
Journal:  Int J Sports Phys Ther       Date:  2016-12

2.  MR imaging of compartment syndrome of the lower leg: a case control study.

Authors:  M B Rominger; C J Lukosch; G F Bachmann
Journal:  Eur Radiol       Date:  2004-04-06       Impact factor: 5.315

3.  Chronic exertional compartment syndrome of the lower extremities: improved screening using a novel dual birdcage coil and in-scanner exercise protocol.

Authors:  Daniel V Litwiller; Kimberly K Amrami; Diane L Dahm; Jay Smith; Edward R Laskowski; Michael J Stuart; Joel P Felmlee
Journal:  Skeletal Radiol       Date:  2007-08-15       Impact factor: 2.199

4.  Noninvasive monitoring of elevated intramuscular pressure in a model compartment syndrome via quantitative fascial motion.

Authors:  John E Lynch; John K Lynch; Steven L Cole; Jonathan A Carter; Alan R Hargens
Journal:  J Orthop Res       Date:  2009-04       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.